Clonal hematopoiesis and differential outcomes after immune checkpoint blockade Research Letter

  

Authors:	Hsiehchen, D.; Sfreddo, H. J.; Zhao, K.; Han, C. Y.; Morris, L. G. T.
Title:	Clonal hematopoiesis and differential outcomes after immune checkpoint blockade
Keywords:	cancer chemotherapy; cancer survival; controlled study; major clinical study; overall survival; genetics; systemic therapy; glioma; antineoplastic agent; letter; colorectal cancer; allele; cancer immunotherapy; melanoma; breast cancer; cohort analysis; bladder cancer; renal cell carcinoma; oncogene; head and neck cancer; stomach cancer; cancer of unknown primary site; drug therapy; esophagus cancer; multiple cancer; predictive value; tet2 gene; pharmacology; programmed death 1 ligand 1; programmed death 1 receptor; non small cell lung cancer; dna methyltransferase 3a; clinical outcome; clonal hematopoiesis; immune checkpoint inhibitor; high throughput sequencing; humans; human; programmed cell death 1 receptor; immune checkpoint inhibitors; malignant neoplasm; b7-h1 antigen
Journal Title:	Cancer Cell
Volume:	40
Issue:	10
ISSN:	1535-6108
Publisher:	Cell Press
Date Published:	2022-10-10
Start Page:	1071
End Page:	1072
Language:	English
DOI:	10.1016/j.ccell.2022.08.024
PUBMED:	36113476
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139409082&doi=10.1016%2fj.ccell.2022.08.024&partnerID=40&md5=b7358963e700be63439325fcdde2a4c2
Notes:	Letter -- Export Date: 1 November 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/199073